BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 29371155)

  • 21. SOX2, OTX2 and PAX6 analysis in subjects with anophthalmia and microphthalmia.
    Mauri L; Franzoni A; Scarcello M; Sala S; Garavelli L; Modugno A; Grammatico P; Patrosso MC; Piozzi E; Del Longo A; Gesu GP; Manfredini E; Primignani P; Damante G; Penco S
    Eur J Med Genet; 2015 Feb; 58(2):66-70. PubMed ID: 25542770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel heterozygous SOX2 mutation causing anophthalmia/microphthalmia with genital anomalies.
    Pedace L; Castori M; Binni F; Pingi A; Grammatico B; Scommegna S; Majore S; Grammatico P
    Eur J Med Genet; 2009; 52(4):273-6. PubMed ID: 19254784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Review of 37 patients with SOX2 pathogenic variants collected by the Anophthalmia/Microphthalmia Clinical Registry and DNA research study.
    Amlie-Wolf L; Bardakjian T; Kopinsky SM; Reis LM; Semina EV; Schneider A
    Am J Med Genet A; 2022 Jan; 188(1):187-198. PubMed ID: 34562068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel SOX2 partner-factor domain mutation in a four-generation family.
    Mihelec M; Abraham P; Gibson K; Krowka R; Susman R; Storen R; Chen Y; Donald J; Tam PP; Grigg JR; Flaherty M; Gole GA; Jamieson RV
    Eur J Hum Genet; 2009 Nov; 17(11):1417-22. PubMed ID: 19471311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel deletion mutation of the
    Zhang Y; Zhang X; Long R; Yu L
    J Genet; 2018 Sep; 97(4):1007-1011. PubMed ID: 30262714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gait disturbance in a patient with de novo 1.0-kb SOX2 microdeletion.
    Yamada H; Okanishi T; Okazaki T; Oguri M; Fukuda H; Uchiyama Y; Mizuguchi T; Matsumoto N; Maegaki Y
    Brain Dev; 2022 Jan; 44(1):68-72. PubMed ID: 34332824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parent-of-origin effects in SOX2 anophthalmia syndrome.
    Osborne RJ; Kurinczuk JJ; Ragge NK
    Mol Vis; 2011; 17():3097-106. PubMed ID: 22171155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted resequencing identifies PTCH1 as a major contributor to ocular developmental anomalies and extends the SOX2 regulatory network.
    Chassaing N; Davis EE; McKnight KL; Niederriter AR; Causse A; David V; Desmaison A; Lamarre S; Vincent-Delorme C; Pasquier L; Coubes C; Lacombe D; Rossi M; Dufier JL; Dollfus H; Kaplan J; Katsanis N; Etchevers HC; Faguer S; Calvas P
    Genome Res; 2016 Apr; 26(4):474-85. PubMed ID: 26893459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Three new PAX6 mutations including one causing an unusual ophthalmic phenotype associated with neurodevelopmental abnormalities.
    Dansault A; David G; Schwartz C; Jaliffa C; Vieira V; de la Houssaye G; Bigot K; Catin F; Tattu L; Chopin C; Halimi P; Roche O; Van Regemorter N; Munier F; Schorderet D; Dufier JL; Marsac C; Ricquier D; Menasche M; Penfornis A; Abitbol M
    Mol Vis; 2007 Apr; 13():511-23. PubMed ID: 17417613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genome-wide copy number analysis and systematic mutation screening in 58 patients with hypogonadotropic hypogonadism.
    Izumi Y; Suzuki E; Kanzaki S; Yatsuga S; Kinjo S; Igarashi M; Maruyama T; Sano S; Horikawa R; Sato N; Nakabayashi K; Hata K; Umezawa A; Ogata T; Yoshimura Y; Fukami M
    Fertil Steril; 2014 Oct; 102(4):1130-1136.e3. PubMed ID: 25064402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SPG11 compound mutations in spastic paraparesis with thin corpus callosum.
    Samaranch L; Riverol M; Masdeu JC; Lorenzo E; Vidal-Taboada JM; Irigoyen J; Pastor MA; de Castro P; Pastor P
    Neurology; 2008 Jul; 71(5):332-6. PubMed ID: 18663179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular findings and clinical data in a cohort of 150 patients with anophthalmia/microphthalmia.
    Chassaing N; Causse A; Vigouroux A; Delahaye A; Alessandri JL; Boespflug-Tanguy O; Boute-Benejean O; Dollfus H; Duban-Bedu B; Gilbert-Dussardier B; Giuliano F; Gonzales M; Holder-Espinasse M; Isidor B; Jacquemont ML; Lacombe D; Martin-Coignard D; Mathieu-Dramard M; Odent S; Picone O; Pinson L; Quelin C; Sigaudy S; Toutain A; Thauvin-Robinet C; Kaplan J; Calvas P
    Clin Genet; 2014 Oct; 86(4):326-34. PubMed ID: 24033328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypogonadotropic hypogonadism in an adult female with a heterozygous hypomorphic mutation of SOX2.
    Sato N; Kamachi Y; Kondoh H; Shima Y; Morohashi K; Horikawa R; Ogata T
    Eur J Endocrinol; 2007 Feb; 156(2):167-71. PubMed ID: 17287405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Supernumerary impacted teeth in a patient with SOX2 anophthalmia syndrome.
    Numakura C; Kitanaka S; Kato M; Ishikawa S; Hamamoto Y; Katsushima Y; Kimura T; Hayasaka K
    Am J Med Genet A; 2010 Sep; 152A(9):2355-9. PubMed ID: 20803647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Syndromic microphthalmia-3 caused by a mutation on gene SOX2 in a Colombian male patient.
    Ramirez-Botero AF; Pachajoa H
    Congenit Anom (Kyoto); 2016 Nov; 56(6):250-252. PubMed ID: 27206652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Case Report: A Novel Point Mutation of
    Li J; Zhong Y; Guo T; Yu Y; Li J
    Front Endocrinol (Lausanne); 2022; 13():810375. PubMed ID: 35295983
    [No Abstract]   [Full Text] [Related]  

  • 37. Mutations in SOX2 cause anophthalmia-esophageal-genital (AEG) syndrome.
    Williamson KA; Hever AM; Rainger J; Rogers RC; Magee A; Fiedler Z; Keng WT; Sharkey FH; McGill N; Hill CJ; Schneider A; Messina M; Turnpenny PD; Fantes JA; van Heyningen V; FitzPatrick DR
    Hum Mol Genet; 2006 May; 15(9):1413-22. PubMed ID: 16543359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [SOX2 defect and anophthalmia and microphthalmia].
    Ye FX; Fan XQ
    Zhonghua Yan Ke Za Zhi; 2012 Nov; 48(11):1049-52. PubMed ID: 23302280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heterozygous mutations in SOX2 may cause idiopathic hypogonadotropic hypogonadism via dominant-negative mechanisms.
    Cassin J; Stamou MI; Keefe KW; Sung KE; Bojo CC; Tonsfeldt KJ; Rojas RA; Ferreira Lopes V; Plummer L; Salnikov KB; Keefe DL; Ozata M; Genel M; Georgopoulos NA; Hall JE; Crowley WF; Seminara SB; Mellon PL; Balasubramanian R
    JCI Insight; 2023 Feb; 8(3):. PubMed ID: 36602867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A SOX3 (Xq26.3-27.3) duplication in a boy with growth hormone deficiency, ocular dyspraxia, and intellectual disability: a long-term follow-up and literature review.
    Stagi S; Lapi E; Pantaleo M; Traficante G; Giglio S; Seminara S; de Martino M
    Hormones (Athens); 2014; 13(4):552-60. PubMed ID: 25402377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.